Company facts
- Headquarters
- Irvine, California
- Most recent report
- 10-Q, filed Aug 6, 2026
- Incorporated
- Delaware
- Filings on record
- 647 filings
- On EDGAR
- CIK 1819790
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 24
News 8 of 69
Prospectuses and Registrations 8 of 22
- S-8 Registration statement for an employee plan Feb 23, 2026
- 424B5 Prospectus supplement for an offering Mar 13, 2025
- 424B5 Prospectus supplement for an offering Mar 12, 2025
- S-8 Registration statement for an employee plan Feb 25, 2025
- 424B5 Prospectus supplement for an offering Mar 1, 2024
- 424B5 Prospectus supplement for an offering Feb 29, 2024
- S-3ASR Automatic shelf registration Feb 29, 2024
- S-8 Registration statement for an employee plan Feb 27, 2024
Proxies 8 of 12
- DEFA14A Extra proxy material Apr 28, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2026
- DEFA14A Extra proxy material Apr 28, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2025
- DEFA14A Extra proxy material Apr 26, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2024
- DEFA14A Extra proxy material Apr 26, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2023
Ownership 8 of 489
- 144 Notice of a proposed sale of restricted stock Aug 19, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 13, 2026
- 4 Insider reported a trade Jun 29, 2026
- 4 Insider reported a trade Jun 29, 2026
- 4 Insider reported a trade Jun 29, 2026
- 4 Insider reported a trade Jun 29, 2026
- 4 Insider reported a trade Jun 29, 2026
- 4 Insider reported a trade Jun 29, 2026
Other 8 of 31
- ARS Annual report sent to shareholders Apr 28, 2026
- ARS Annual report sent to shareholders Apr 28, 2025
- ARS Annual report sent to shareholders Apr 26, 2024
- EFFECT Notice that a registration became effective Nov 21, 2023
- CORRESP Reply to SEC staff Nov 17, 2023
- UPLOAD Comment letter from SEC staff Nov 16, 2023
- ARS Annual report sent to shareholders Apr 26, 2023
- UPLOAD Comment letter from SEC staff Apr 18, 2023
Everything here comes from Tarsus Pharmaceuticals, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.